GBUZ Nizhegorodskay Region: Clinical Diagnostic Center

Nizhny Novgorod, Niznij Novgorod 603001

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed